Yatharth Hospital & Trauma Care Services Limited reported a 51% year-on-year surge in consolidated revenue to ₹3,927 million for Q1FY27, driven by strong volume growth and the scaling of newer hospital acquisitions. Profit after tax (PAT) rose 8% to ₹454 million from ₹420 million in the corresponding period last year. The company’s adjusted EBITDA margin stood at a robust 28.1%, excluding ramp-up losses from new facilities, while new hospitals contributed 27% to the total revenue mix, up from 22% in Q4FY26.

The results were presented pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing highlights that Faridabad Sector-20 achieved EBITDA breakeven in a record nine months, while the Agra hospital delivered an EBITDA margin exceeding 20% in its first full quarter of integration. Management also announced the first interim dividend of 5% of face value and approved ESOP grants under the ESOP Scheme 2024 and a new ESOP Scheme 2026.

Financial Performance Overview

Revenue grew 15% quarter-on-quarter from ₹3,416 million in Q4FY26. Employee expenses rose 61.7% YoY to ₹779 million, reflecting staffing additions for new units, while other expenses increased 65.4% to ₹1,537 million. Depreciation and amortization nearly doubled to ₹282 million from ₹149 million year-ago.

Operational Highlights and Expansion

Operational census beds reached 1,820 with an occupancy rate of 68%. Average Revenue Per Occupied Bed (ARPOB) increased 7% YoY to ₹34,758, supported by premium patient mixes in NCR hospitals like New Delhi and Noida Extension, which are approaching ₹50,000 ARPOB. Inpatient Department (IPD) volumes rose to 30,000 from 19,000, while Outpatient Department (OPD) volumes grew to 139,000 from 105,000.

New hospitals—Greater Faridabad, New Delhi Model Town, Faridabad Sector-20, and Agra—generated ₹1,067 million in revenue. The Gurugram facility, acquired for ₹100 crore with an additional ₹100 crore outlay for equipment, is expected to commence operations by Q1FY28. The company targets expanding its bed capacity to approximately 5,000 beds over the next three years, up from the current announced capacity of 3,255 beds.

What the Numbers Show

The divergence between reported EBITDA margin (23.3%) and adjusted EBITDA margin (28.1%) underscores the transitional cost structure associated with rapid expansion. While top-line growth accelerated significantly, operating leverage was temporarily impacted by ramp-up losses in newer assets. However, the quick path to profitability at Faridabad Sector-20 and high margins at Agra validate the acquisition playbook, suggesting that normalized margins should recover as these units scale towards full occupancy.

The Nomination and Remuneration Committee (NRC) of yatharth hospital approved the grant of 250,000 employee stock options to eligible staff members on August 10, 2026. The move aligns with the company’s strategy to retain talent through equity-based incentives under the Yatharth Hospital & Trauma Care Services Employee Stock Option Scheme - 2024.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III and SEBI Master Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026. The NRC meeting commenced at 11:15 AM IST and concluded at 11:50 AM IST.

Key Terms of the Grant

The granted options are convertible into an equal number of equity shares with a face value of ₹10 each. The exercise price for these options is set at ₹10 per option, equivalent to the face value of the company’s equity shares. This pricing structure ensures that the exercise price does not fall below the statutory minimum while providing a clear cost basis for employees upon vesting.

Vesting and Exercise Conditions

Options will begin vesting one year from the grant date, extending up to a maximum of four years, as determined by the Committee in the Grant Letter. In cases of death or permanent disability of a grantee, the minimum one-year vesting period is waived, and options vest immediately in accordance with SEBI (Share Based Employee Benefits & Sweat Equity) Regulations, 2021.

Once vested, employees may exercise their options wholly or partially within two years from the respective vesting date. The Committee retains discretion to open specific exercise windows during this period. The scheme will be implemented via fresh allotment of shares directly to eligible employees.

What the Numbers Show

The grant of 250,000 options at par value (₹10) indicates a conservative approach to dilution, likely targeting broad-based employee retention rather than high-value executive compensation. With full exercise potential leading to 250,000 new shares, the impact on existing shareholders’ equity will depend on actual vesting rates and future share price movements relative to the fixed exercise price.